Biotech RadarJobs updated

COMPANY

Accuray

HQ: Madison, WI source · accuray.com ↗ · Midwest

FDA-cleared device company Past trials only

25 open jobs · last seen Oct 23, 2026 · 9 sources

Designs radiotherapy solutions for complex and commonly treatable cases. Source

Keywords: radiotherapy oncology Prostate Cancer Prostatic Cancer Prostate Neoplasms Prostatic Neoplasms Cancer of the Prostate Non-small Cell Lung Cancer Colorectal Liver Metastases Recurrent Hepatocellular Carcinoma CyberKnife Stereotactic Radiosurgery CyberKnife SBRT

Profile checked Oct 10, 2026

Since the raise (Oct 6, 2026): 2 of 25 open jobs were first seen after it.

25Open jobs$40.0MRaised (2 yrs)6Trials (company is sponsor)1NIH grants

Hiring

TitleLocation (from posting)Employer postedFirst seen
Field Service Engineer - St. LouisRemote - USOct 22, 2026Oct 5, 2026
EHS SpecialistMadison, WIOct 20, 2026Oct 5, 2026
Motion Controls & Robotics Software EngineerMadison, WIOct 16, 2026Oct 5, 2026
Senior Human Resources Business PartnerMadison, WIOct 13, 2026Oct 5, 2026
Manager of TreasuryMadison, WIOct 13, 2026Oct 14, 2026

See all 25 jobs

Timeline

  1. Raise Private placement: $40M (total, as published), announced Oct 6, 2026. Source: SEC filing. source ↗
  2. Board tracked Radar started tracking this company’s job board (25 open jobs at last check). source ↗
  3. Trial start Phase 3: Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC) source ↗
  4. Trial start Phase 2: CyberKnife® for Hepatic Metastases From Colorectal Cancer source ↗
  5. Trial start Not phased (device or behavioral study): Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer source ↗
  6. Trial start Not phased (device or behavioral study): CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution source ↗
  7. Trial start Not phased (device or behavioral study): CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry source ↗
  8. Trial start Phase 2: CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer source ↗

Open jobs 25

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Field Service Engineer - St. LouisRemote - USOct 22, 2026Oct 5, 2026Mid
EHS SpecialistMadison, WIOct 20, 2026Oct 5, 2026Mid
Motion Controls & Robotics Software EngineerMadison, WIOct 16, 2026Oct 5, 2026Senior
Senior Human Resources Business PartnerMadison, WIOct 13, 2026Oct 5, 2026Senior
Manager of TreasuryMadison, WIOct 13, 2026Oct 14, 2026Senior
Reliability EngineerMadison, WIOct 9, 2026Oct 5, 2026Mid
Production AssemblerMadison, WIOct 9, 2026Oct 9, 2026Entry
Senior Motion Controls & Robotics Software EngineerMadison, WIOct 2, 2026Oct 5, 2026Senior
Systems EngineerMadison, WIOct 2, 2026Oct 5, 2026Mid
Service Finance AnalystMadison, WIOct 2, 2026Oct 5, 2026Mid
Software EngineerMadison, WIOct 2, 2026Oct 5, 2026Mid
Sourcing Data Management InternMadison, WIOct 1, 2026Oct 5, 2026Entry
Director of Global Service FinanceMadison, WISep 28, 2026Oct 5, 2026Senior
Corporate FP&A ManagerMadison, WISep 23, 2026Oct 5, 2026Mid
Sr Category Sourcing Manager - Electronic ComponentsMadison, WISep 23, 2026Oct 5, 2026Senior
Manager, Genolier Training Center & Strategic PartnershipsGenolierSep 23, 2026Oct 5, 2026Mid
Data Privacy and Responsible AI ManagerRemote U.S.Sep 23, 2026Oct 5, 2026Mid
Sales Manager IndonesiaRemote - IndonesiaSep 23, 2026Oct 5, 2026Mid
Clinical Success Manager EMEA – UK & IrelandRemote - UKSep 23, 2026Oct 5, 2026Mid
Senior Verification and Validation EngineerMadison, WISep 23, 2026Oct 5, 2026Senior
Fullstack EngineerMadison, WISep 23, 2026Oct 5, 2026Mid
Field Service Engineer Talent Community - General InterestRemote - USSep 23, 2026Oct 5, 2026Not stated
Operations and Production Talent Community - General InterestMadison, WISep 23, 2026Oct 5, 2026Not stated
Supplier Quality Talent Community - General Interest PipelineMadison, WISep 23, 2026Oct 5, 2026Not stated
Engineering Talent Community - General Interest PipelineMadison, WISep 23, 2026Oct 5, 2026Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Funding

Raised: $40.0M. Last 2 years.

Clinical trials (lead sponsor) 6

RecordTitlePhaseStatusStartPrimary completion
NCT00643994CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose DistributionNot phased (device or behavioral study)Completed2007-12Jan 27, 2021 (actual)
NCT00643617CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy DosimetryNot phased (device or behavioral study)CompletedOct 22, 2007Apr 7, 2022 (actual)
NCT00643318CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung CancerPhase 2Unknown status (ClinicalTrials.gov)2006-042021-12 (estimated)
NCT00840749Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung CancerNot phased (device or behavioral study)Terminated2008-122013-03 (actual)
NCT01318447CyberKnife® for Hepatic Metastases From Colorectal CancerPhase 2Terminated2011-012013-03 (actual)
NCT01318200Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)Phase 3Withdrawn2011-022014-02 (estimated)

NIH awards 1

Annual award amounts. Total $100K.

Connect

See your connections at Accuray on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-14

Feedback